Stephens Downgrades Catalyst Pharmaceutical Partners (CPRX) to Equal Weight
Tweet Send to a Friend
Stephens analyst Sudan Loganathan downgraded Catalyst Pharmaceutical Partners (NASDAQ: CPRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
